Piper Sandler Starts Acelyrin Inc (SLRN) at Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. AMD
3. PLTR
4. CRWD
5. DOX
6. VRTX
7. CHKP
8. BKNG
9. ON
10. EL

Go back to Piper Sandler Starts Acelyrin Inc (SLRN) at Overweight

Acelyrin (SLRN) risk/reward 'skewed to the upside'

May 30, 2023 1:26 PM EDT

Acelyrin (NASDAQ: SLRN) was initiated at Overweight with a $29 price target by Morgan Stanley in a note Tuesday.

Analyst Vikram Purohit told investors that the company's late-stage immunology pipeline is addressing large areas of unmet needs.

"Acelyrin's lead pipeline program is izokibep," the analyst stated. "PhII data for... More

Morgan Stanley Starts Acelyrin Inc (SLRN) at Overweight

May 30, 2023 10:05 AM EDT

Morgan Stanley analyst Vikram Purohit initiates coverage on Acelyrin Inc (NASDAQ: SLRN) with an Overweight rating and a price target of $29.00.

The analyst commented, "We initiate at Overweight with a $29 PT. PhII data for izokibep suggests strong potential for differentiation in I&I indications... More